Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 100.99 USD 0.01% Market Closed
Market Cap: 3.3B USD

Intrinsic Value

The intrinsic value of one AMED stock under the Base Case scenario is 114.35 USD. Compared to the current market price of 100.99 USD, Amedisys Inc is Undervalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMED Intrinsic Value
114.35 USD
Undervaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Amedisys Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about AMED?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AMED valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Amedisys Inc.

Explain Valuation
Compare AMED to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AMED?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amedisys Inc

Current Assets 662.2m
Cash & Short-Term Investments 337.3m
Receivables 295.5m
Other Current Assets 29.4m
Non-Current Assets 1.6B
Long-Term Investments 117m
PP&E 124.9m
Intangibles 1.3B
Other Non-Current Assets 18.2m
Current Liabilities 488.4m
Accounts Payable 29.8m
Accrued Liabilities 315.8m
Other Current Liabilities 142.8m
Non-Current Liabilities 494.5m
Long-Term Debt 326.4m
Other Non-Current Liabilities 168.1m
Efficiency

Free Cash Flow Analysis
Amedisys Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Amedisys Inc

Revenue
2.4B USD
Cost of Revenue
-1.4B USD
Gross Profit
1B USD
Operating Expenses
-811.6m USD
Operating Income
226m USD
Other Expenses
-140.4m USD
Net Income
85.6m USD
Fundamental Scores

AMED Profitability Score
Profitability Due Diligence

Amedisys Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Operating Margin
Declining Gross Margin
47/100
Profitability
Score

Amedisys Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

AMED Solvency Score
Solvency Due Diligence

Amedisys Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Negative Net Debt
62/100
Solvency
Score

Amedisys Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMED Price Targets Summary
Amedisys Inc

There are no price targets for AMED.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Amedisys Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AMED is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AMED Insider Trading
Buy and sell transactions by insiders

AMED News

Other Videos
What is the Intrinsic Value of one AMED stock?

The intrinsic value of one AMED stock under the Base Case scenario is 114.35 USD.

Is AMED stock undervalued or overvalued?

Compared to the current market price of 100.99 USD, Amedisys Inc is Undervalued by 12%.

Back to Top